Abstract
Objectives
Synovial sarcomas (SS) of the extremities are rare soft tissue sarcomas that are more common in young adults. We deciphered the imaging phenotype of SS with the aim to determine if imaging could provide an incremental value to currently known prognostic factors (PF)—age and histological grade—to predict long-term overall survival (OS).
Methods
This retrospective multicenter study included consecutive pediatric and adult patients with synovial sarcomas of the extremities from December 2002 to August 2020. Inclusion criteria were (i) a follow-up greater than 5 years and (ii) available pre-therapeutic MRI. A subset analysis included MRI and CT-scan. Clinical, pathological, and imaging variables were collected in all patients. The primary endpoint was to evaluate the association of these variables with OS using univariate and multivariate Cox regressions.
Results
Out of 428 patients screened for eligibility, 98 patients (mean age: 37.1 ± 15.2 years) were included (MRI: n = 98/98, CT scan: n = 34/98; 35%). The median OS was 75.25 months (IQR = 55.50–109.12) and thirty-six patients (n = 36/98;37%) died during follow-up. The recurrence rate was 12.2% (n =12/98). SS lesions were mostly grade 2 (57/98; 58%). On MRI, SS had a mean long-axis diameter of 67.5 ± 38.3 mm. On CT scan, 44% (15/34) were calcified. Grade (hazard ratio [HR] = 2.71; 95%CI = 1.30–5.66; p = 0.008), size of the lesions evaluated on MRI (HR = 1.02; 95% CI = 1.01–1.03; p < 0.001), and calcifications on CT scan (HR = 0.10; 95% CI = 0.02–0.50; p = 0.005) were independent PF of OS.
Conclusions
This study demonstrated that imaging biomarkers can be used to predict long-term outcome in patients with SS. Strikingly, the presence of calcifications on CT scan is associated with favorable outcome and provides an incremental value over existing PF such as age, grade, and size.
Key points
• Beyond its diagnostic value, MRI is a pre-operative prognostic tool in synovial sarcomas of the extremities since the size of the lesion is an important prognostic factor.
• Calcifications on CT scans are independently and significantly associated with prolonged overall survival.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- FNCLCC:
-
Fédération Nationale des Centres de Lutte Contre le Cancer
- LFS:
-
Local recurrence-free survival
- MFS:
-
Metastasis-free survival
- MRI:
-
Magnetic resonance imaging
- OS:
-
Overall survival
- PF:
-
Prognostic factor
- SS:
-
Synovial sarcoma
- WI:
-
Weighted imaging
References
Fletcher C, Bridge J, Hogendoorn P, Mertens F WHO Classification of tumours of soft tissue and bone
National Cancer Institute SEER database: incidence - SEER cancer statistics review 1975-2017, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch.Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov)
Sreekantaiah C, Ladanyi M, Rodriguez E, Chaganti RS (1994) Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms. Am J Pathol 144:1121–1134
van der Graaf WTA, Orbach D, Judson IR, Ferrari A (2017) Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts. Lancet Oncol 18:e166–e175. https://doi.org/10.1016/S1470-2045(17)30099-2
Park JH, Kang CH, Kim CH et al (2010) Highly malignant soft tissue sarcoma of the extremity with a delayed diagnosis. World J Surg Oncol 8:84. https://doi.org/10.1186/1477-7819-8-84
Kransdorf MJ, Murphey MD (2013) Imaging of soft tissue tumors, 3 edition. Lippincott Williams & Wilkins, Philadelphia
Murphey MD, Gibson MS, Jennings BT et al (2006) Imaging of synovial sarcoma with radiologic-pathologic correlation. Radiographics 26:1543–1565. https://doi.org/10.1148/rg.265065084
Bermejo A, De Bustamante TD, Martinez A et al (2013) MR imaging in the evaluation of cystic-appearing soft-tissue masses of the extremities. Radiographics 33:833–855. https://doi.org/10.1148/rg.333115062
Krieg AH, Hefti F, Speth BM et al (2011) Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors. Ann Oncol 22:458–467. https://doi.org/10.1093/annonc/mdq394
Gundle KR, Kafchinski L, Gupta S et al (2018) Analysis of margin classification systems for assessing the risk of local recurrence after soft tissue sarcoma resection. J Clin Oncol 36:704–709. https://doi.org/10.1200/JCO.2017.74.6941
Yoo HJ, Hong SH, Kang Y et al (2014) MR imaging of myxofibrosarcoma and undifferentiated sarcoma with emphasis on tail sign; diagnostic and prognostic value. Eur Radiol 24:1749–1757. https://doi.org/10.1007/s00330-014-3181-2
Seo SW, Kim J, Son J, Lim S (2020) Evaluation of conditional treatment effects of adjuvant treatments on patients with synovial sarcoma using Bayesian subgroup analysis. BMC Med Inform Decis Mak 20:320. https://doi.org/10.1186/s12911-020-01305-9
Wilkerson BW, Crim JR, Hung M, Layfield LJ (2012) Characterization of synovial sarcoma calcification. AJR Am J Roentgenol 199:W730–W734. https://doi.org/10.2214/AJR.11.7342
Varela-Duran J, Enzinger FM (1982) Calcifying synovial sarcoma. Cancer 50:345–352. https://doi.org/10.1002/1097-0142(19820715)50:2<345::AID-CNCR2820500231>3.0.CO;2-Y
Ud Din N, Hopkins A, Memon A et al (2015) Calcifying/ossifying synovial sarcoma: a clinicopathologic and molecular study of 5 cases. Indian J Pathol Microbiol 58:55–58. https://doi.org/10.4103/0377-4929.151188
Baptista AM, de Camargo OP, Croci AT et al (2006) Synovial sarcoma of the extremities: prognostic factors for 20 nonmetastatic cases and a new histologic grading system with prognostic significance. Clinics 61:381–386. https://doi.org/10.1590/S1807-59322006000500003
Tateishi U, Hasegawa T, Beppu Y et al (2004) Synovial sarcoma of the soft tissues: prognostic significance of imaging features. J Comput Assist Tomogr 28:140–148. https://doi.org/10.1097/00004728-200401000-00024
Kirkham M, Kalivas A, Fatema K et al (2020) Underlying ossification phenotype in a murine model of metastatic synovial sarcoma. Int J Mol Sci 21:2636. https://doi.org/10.3390/ijms21072636
Mandard AM, Petiot JF, Marnay J et al (1989) Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer 63:1437–1451. https://doi.org/10.1002/1097-0142(19890401)63:7<1437::aid-cncr2820630735>3.0.co;2-q
Merimsky O, Isakov J, Kollender Y et al (1998) Vascular invasion in high grade sarcoma of the extremity is associated with short overall survival. Oncol Rep 5:985–989. https://doi.org/10.3892/or.5.4.985
Tang YM, Stuckey S, Lambie D, Strutton GM (2006) Macroscopic vascular invasion in synovial sarcoma evident on MRI. Skeletal Radiol 35:783–786. https://doi.org/10.1007/s00256-005-0934-7
Fujiwara T, Medellin MR, Sambri A et al (2019) Preoperative surgical risk stratification in osteosarcoma based on the proximity to the major vessels. Bone Joint J 101-B:1024–1031. https://doi.org/10.1302/0301-620X.101B8.BJJ-2018-0963.R1
Holzapfel K, Regler J, Baum T et al (2015) Local staging of soft-tissue sarcoma: emphasis on assessment of neurovascular encasement-value of MR imaging in 174 confirmed cases. Radiology 275:501–509. https://doi.org/10.1148/radiol.14140510
Engellau J, Bendahl P-O, Persson A et al (2005) Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays. Hum Pathol 36:994–1002. https://doi.org/10.1016/j.humpath.2005.07.008
Sultan I, Rodriguez-Galindo C, Saab R et al (2009) Comparing children and adults with synovial sarcoma in the surveillance, epidemiology, and end results program, 1983 to 2005: an analysis of 1268 patients. Cancer 115:3537–3547. https://doi.org/10.1002/cncr.24424
Vlenterie M, Ho VKY, Kaal SEJ et al (2015) Age as an independent prognostic factor for survival of localised synovial sarcoma patients. Br J Cancer 113:1602–1606. https://doi.org/10.1038/bjc.2015.375
Spillane AJ, A’Hern R, Judson IR et al (2000) Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol 18:3794–3803. https://doi.org/10.1200/JCO.2000.18.22.3794
Smolle MA, Parry M, Jeys L et al (2019) Synovial sarcoma: do children do better? Eur J Surg Oncol 45:254–260. https://doi.org/10.1016/j.ejso.2018.07.006
Bianchi G, Sambri A, Righi A et al (2017) Histology and grading are important prognostic factors in synovial sarcoma. Eur J Surg Oncol 43:1733–1739. https://doi.org/10.1016/j.ejso.2017.05.020
Xiong L, Chen Z, Zhou Y et al (2020) The survival and prognosis analysis of synovial sarcoma subtypes: a surveillance, epidemiology, and end results population-based analysis. Int Orthop 44:2779–2786. https://doi.org/10.1007/s00264-020-04708-5
Crombé A, Marcellin P-J, Buy X et al (2019) Soft-tissue sarcomas: assessment of MRI features correlating with histologic grade and patient outcome. Radiology 291:710–721. https://doi.org/10.1148/radiol.2019181659
de Silva MVC, McMahon AD, Reid R (2004) Prognostic factors associated with local recurrence, metastases, and tumor-related death in patients with synovial sarcoma. Am J Clin Oncol 27:113–121. https://doi.org/10.1097/01.coc.0000047129.97604.D6
Funding
The authors state that this work has not received any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Mickael Tordjman.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
Pierre-Alban Bouché and David Biau kindly provided statistical advice for this manuscript. They have significant statistical expertise.
Informed consent
Written informed consent was obtained from all subjects (patients or family of deceased) in this study.
Ethical approval
Institutional Review Board approval was obtained.
Methodology
• retrospective
• diagnostic or prognostic study
• multicenter study
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 1889 kb)
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Tordjman, M., Honoré, C., Crombé, A. et al. Prognostic factors of the synovial sarcoma of the extremities: imaging does matter. Eur Radiol 33, 1162–1173 (2023). https://doi.org/10.1007/s00330-022-09049-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-022-09049-y